High prevalence of hyperhomocysteinemia in critically ill patients: Vascular damage and adequate vitamin intake

e-SPEN

Volumn 3, Issue 5, 2008, Pages

  Abilés, Jimena ^a   Abúd, Rocio Pérez ^a   Moratalla, Gonzalo ^a   Castaño, José ^a   Elvira, Manuel Rodríguez ^a   Pérez de la Cruz, Antonio ^a   Moreno Torres Herrera, Rosario ^a   Planells del Pozo, Elena M ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

B12 vitamin; Critically ill patients; Folic acid; Homocysteine; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; CYANOCOBALAMIN; D DIMER; FOLIC ACID; HOMOCYSTEINE; LIPID PEROXIDE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; ENDOTHELIUM LESION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; LIPID BLOOD LEVEL; MALE; MEDICAL RECORD; OXIDATIVE STRESS; PREVALENCE; RISK REDUCTION; SPECTROPHOTOMETRY; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 52049110741     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2008.06.011     Document Type: Article

References (30)

1. Lovatand R., and Preiser J.C. Antioxidant therapy in intensive care. Curr Opin Crit Care 9 (2003) 266-270
2. Goodyer-Bruch C., and Pierce J.D. Oxidative stress in critically ill patients. Am J Crit Care 11 (2002) 543-551
3. Isowa N., and Wada H. Oxidative stress and ischemia-reperfusion induced acute lung injury. N Surg J 1 (2002) 1-19
4. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
5. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?. Crit Care (2003) 130-138
6. Selhab J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136 6 Suppl (2006) 1726S-1730S
7. Mudd S.H., Levy H.L., and Skovby F. Disorders of transsulfuration. In: Scriver C.R., Beaudet A.L., and Sly W.S. (Eds). The metabolic and molecular basis of inherited disease. 1st ed. (1995), McGraw-Hill, New York
8. Durand P., Prost M., Lussier-Cacan S., Loreau N., Lussier-Cacan S., and Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 81 (2001) 645-672
9. Refsum H., and Smith A.D. HomocysteineB vitamins, and cardiovascular disease. N Engl J Med 13 2 (2006) 207
10. Schindler K., Zauner C., Buchmayer H., Födinger M., Wölfl G., Bieglmayer C., et al. High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med 28 84 (2000) 991-995
11. Frost S.D., Brotman D.J., and Michota F.A. Rationale use of D-dimer measurement to exclude acute venous thromboembolic disease. Mayo Clin Proc 78 (2003) 1385-1391
12. Levine R.L., Wehr N., Williams J.A., Stadman E.R., and Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 99 (2000) 15-24
13. 2+ in the presence of xylenol orange. Comparison with the TBA assay and idometric method. Lipids 26 (1991) 407-421
14. Villaño D., Fernandez-Pachón S., Troncoso A.M., and García-Parrilla M.C. Comparison of antioxidant activity of wine phenolic compounds and metabolites in vitro. Anal Chim Acta 538 (2005) 91-98
15. Jacobsen D. Determinants of hyperhomocysteinemia: a matter of nature or nurture. Am J Clin Nutr 64 (1996) 641
16. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adults and pediatric patients. J Parenter Enteral Nutr 26 (2002) 1S-138S
17. den Heijer M., Willems H.P., Blom H.J., Gerrits W.B., Cattaneo M., Eichinger S., et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 109 1 (2007) 139-144
18. Austin P.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 (2004) S56-S64
19. Lentz S.R., Piegors D.J., Fernandez J.A., Erger R.A., Arning E., and Malinow M.R. Effect of hyperhomocysteinemia on protein C activation and activity. Blood 101 6 (2003) 2108-2112
20. Harpel P.C., Zhang X., and Borth W. Homocysteine and hemostasis: pathogenetic mechanisms predisposing to thrombosis. J Nutr 126 Suppl (1996) 1285S-1289S
21. Mizock B.A. Homocysteine and critical illness. Crit Care Med 18 (2006) 1-2
22. Dudman N.P.B., Temple S.E., Guo X.W., Fu W., and Perry M.A. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84 4 (1999) 409-416
23. Upchurch G.R., Welch G.N., and Loscalzo J. HomocysteineEDRF and endothelial function. J Nutr 126 Suppl (1996) 1290S-1294S
24. Bolander-Gouaille C. The homocysteine metabolism. In: Bolander-Gouaille C. (Ed). Focus on homocysteine and the vitamins involved in its metabolism. 2nd ed. (2002), Springer, France 20-25
25. Aukrust P., Berge R.K., and Muller F. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency a marker of enhanced oxidative stress. Eur J Clin Invest 27 (1997) 723-730
26. Voutilainen S., Morrow J.D., Roberts II L.J., Alfthan G., Alho H., Nyyssönen K., et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19 (1999) 1263-1266
27. Abilés J., Pérez de la Cruz A., Castaño J., Rodriguez-Elvira M., Aguayo E., Moreno-Torres R., et al. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care 10 5 (2006) 1-9
28. Homocysteine Lowering Trialists's Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82 (2005) 806-812
29. Malinow M.R., Duell P.B., and Hess D.L. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338 (1998) 1009-1015
30. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intake. JAMA 274 (1995) 1049-1057